Question 1

Who are the top researchers at BridgeBio (United States)?

Accepted Answer

Ranked on the quality score, Jean‐François Tamby, Jonathan C. Fox and Alan X. Ji lead among researchers whose main affiliation is BridgeBio (United States).

Question 2

What are the most cited papers from BridgeBio (United States)?

Accepted Answer

The most cited paper from BridgeBio (United States) is "Three-dimensional chromatin landscapes in T cell acute lymphoblastic leukemia" (Andreas Kloetgen et al., 2020), with 238 citations. Next come "Evaluating the state of the science for adeno-associated virus integration: An integrated perspective" (214) and "Efficacy of Acoramidis on All-Cause Mortality and Cardiovascular Hospitalization in Transthyretin Amyloid Cardiomyopathy" (57).

Question 3

Which research topics does BridgeBio (United States) publish most on?

Accepted Answer

By volume in 2022-now: Amyloidosis: Diagnosis, Treatment, Outcomes, Parathyroid Disorders and Treatments, Sarcoidosis and Beryllium Toxicity Research and Potassium and Related Disorders.

Question 4

Which keywords describe research at BridgeBio (United States)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Diagnosis, Treatment, Prognosis, Cardiac Amyloidosis, Transthyretin, Chronic Kidney Disease, Parathyroid Hormone and FGF23.

Question 5

Which fields of science does BridgeBio (United States) work in?

Accepted Answer

In 2022-now, 51% of research at BridgeBio (United States) is in Health Sciences, 40% in Life Sciences. Its largest fields are Medicine (49%), Biochemistry, Genetics and Molecular Biology (37%), Engineering (2%). It does 2.0× the world's share of Life Sciences.

Question 6

Is BridgeBio (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 378% higher than in 2018-2021.